| Year |
Citation |
Score |
| 2017 |
Maize KM, Shah R, Strom A, Kumarapperuma SC, Zhou AL, Wagner CR, Finzel BC. A Crystal Structure-Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides. Molecular Pharmaceutics. PMID 28968488 DOI: 10.1021/Acs.Molpharmaceut.7B00664 |
0.691 |
|
| 2017 |
Maize KM, Shah R, Strom A, Kumarapperuma S, Wagner CR, Finzel BC. A structure-based guide to building hHint-1 activated nucleotide prodrugs Acta Crystallographica Section a Foundations and Advances. 73: a300-a300. DOI: 10.1107/S0108767317097069 |
0.519 |
|
| 2016 |
Shah R, Petersburg J, Gangar AC, Fegan A, Wagner CR, Kumarapperuma SC. In vivo Evaluation of Site-specifically PEGylated Chemically Self-assembled Protein Nanostructures. Molecular Pharmaceutics. PMID 26985775 DOI: 10.1021/Acs.Molpharmaceut.6B00110 |
0.697 |
|
| 2016 |
Sachdev D, Donguyen H, Kobayashi N, Kumarapperuma SC, Weber JC. Abstract 4248: Functional imaging markers for blockade of breast cancer metastasis by IGF1R and insulin receptor targeted drugs using novel MRI and targeted iron oxide nanoparticles Cancer Research. 76: 4248-4248. DOI: 10.1158/1538-7445.Am2016-4248 |
0.301 |
|
| 2013 |
Rashidian M, Kumarapperuma SC, Gabrielse K, Fegan A, Wagner CR, Distefano MD. Simultaneous dual protein labeling using a triorthogonal reagent. Journal of the American Chemical Society. 135: 16388-96. PMID 24134212 DOI: 10.1021/Ja403813B |
0.635 |
|
| 2013 |
Gangar A, Fegan A, Kumarapperuma SC, Huynh P, Benyumov A, Wagner CR. Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures. Molecular Pharmaceutics. 10: 3514-8. PMID 23829765 DOI: 10.1021/Mp400164F |
0.732 |
|
| 2012 |
Fegan A, Kumarapperuma SC, Wagner CR. Chemically self-assembled antibody nanostructures as potential drug carriers. Molecular Pharmaceutics. 9: 3218-27. PMID 23013206 DOI: 10.1021/Mp300303K |
0.638 |
|
| 2012 |
Gangar A, Fegan A, Kumarapperuma SC, Wagner CR. Programmable self-assembly of antibody-oligonucleotide conjugates as small molecule and protein carriers. Journal of the American Chemical Society. 134: 2895-7. PMID 22296405 DOI: 10.1021/Ja210894G |
0.747 |
|
| 2010 |
McDowell M, Gonzales SR, Kumarapperuma SC, Jeselnik M, Arterburn JB, Hanley KA. A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. Antiviral Research. 87: 78-80. PMID 20416341 DOI: 10.1016/J.Antiviral.2010.04.007 |
0.592 |
|
| 2008 |
Chung DH, Kumarapperuma SC, Sun Y, Li Q, Chu YK, Arterburn JB, Parker WB, Smith J, Spik K, Ramanathan HN, Schmaljohn CS, Jonsson CB. Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Research. 79: 19-27. PMID 18394724 DOI: 10.1016/J.Antiviral.2008.02.003 |
0.607 |
|
| 2008 |
Arterburn J, Kumarapperuma S, Jeselnik M, Chung D, Sun Y, Parker W, Chu YK, Jonsson C. Design, Synthesis and Evaluation of 3-Ethynyl-Azole Nucleosides with Antiviral Activity Against Hantaviruses Antiviral Research. 78: A33. DOI: 10.1016/J.Antiviral.2008.01.057 |
0.588 |
|
| 2007 |
Kumarapperuma SC, Sun Y, Jeselnik M, Chung K, Parker WB, Jonsson CB, Arterburn JB. Structural effects on the phosphorylation of 3-substituted 1-beta-D-ribofuranosyl-1,2,4-triazoles by human adenosine kinase. Bioorganic & Medicinal Chemistry Letters. 17: 3203-7. PMID 17379518 DOI: 10.1016/J.Bmcl.2007.03.018 |
0.596 |
|
| Show low-probability matches. |